During the past decade, National Medical Research Center of Cardiology of MoH of Russian Federation conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 8 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 7 clinical trials were completed. i.e. 63.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Medical Research Center of Cardiology of MoH of Russian Federation" #1 sponsor was "Actelion" with 10 trials, followed by "National Medical Research Center for Cardiology, Ministry of Health of Russian Federation" with 4 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Kowa Research Institute, Inc." with 2 trials sponsored and "Servier Russia" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Medical Research Center of Cardiology of MoH of Russian Federation" #1 collaborator was "Heart and Vascular Center Bad Bevensen, Germany" with 1 trials as a collaborator, "I.M. Sechenov First Moscow State Medical University" with 1 trials as a collaborator, "Meshalkin National Medical Research Center, Ministry of Health of Russian Federation" with 1 trials as a collaborator, "Ministry of Health of Russian Federation" with 1 trials as a collaborator and "Ministry of Health of the Russian Federation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "National Medical Research Center of Cardiology of MoH of Russian Federation" are "Pulmonary Arterial Hypertension" (5 trials), "Chronic Thromboembolic Pulmonary Hypertension" (4 trials), "Arterial Hypertension" (2 trials), "Severe Hypertriglyceridemia" (2 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "National Medical Research Center of Cardiology of MoH of Russian Federation" in a lesser frequency.

Most popular intervention types in "National Medical Research Center of Cardiology of MoH of Russian Federation" are "Drug" (21 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Macitentan" (4 trials), "Fenofibrate" (2 trials), "K-877" (2 trials) and "Macitentan 10 mg" (2 trials). Other intervention names were less common.

The vast majority of trials in "National Medical Research Center of Cardiology of MoH of Russian Federation" are 23 trials for "All" genders.

Currently, there are NaN active trials in "National Medical Research Center of Cardiology of MoH of Russian Federation". undefined are not yet recruiting, 6 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 11 completed trials in National Medical Research Center of Cardiology of MoH of Russian Federation, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in National Medical Research Center of Cardiology of MoH of Russian Federation, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".

National Medical Research Center of Cardiology of MoH of Russian Federation has several departments that took part in Clinical trials: "Russian Cardiology Scientific and Production Complex" - 5 trials, "Federal State Budgetary Institution NATIONAL MEDICAL RESEARCH CENTRE OF CARDIOLOGY NAMED AFTER ACADEMICIAN E.I.CHAZOV. of the Ministry of Health of the Russian Federation" - 2 trials